Dodecanedioic acid prevents and reverses metabolic-associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet-induced obesity

被引:3
作者
Angelini, Giulia [1 ,2 ]
Russo, Sara [1 ,2 ]
Carli, Fabrizia [3 ]
Infelise, Patrizia [3 ]
Panunzi, Simona [4 ]
Bertuzzi, Alessandro [5 ]
Caristo, Maria Emiliana [1 ]
Lembo, Erminia [1 ,2 ]
Calce, Roberta [1 ,2 ]
Bornstein, Stefan R. [6 ,7 ]
Gastaldelli, Amalia [3 ]
Mingrone, Geltrude [1 ,2 ,7 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Translat Med & Surg, Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Dept Med & Surg Sci, Rome, Italy
[3] Natl Res Council CNR, Inst Clin Physiol IFC, Cardiometab Risk Lab, Pisa, Italy
[4] CNR, Lab Biomatemat, Ist Anal Sistemi & Informat A Ruberti, IASI, Rome, Italy
[5] CNR, Lab Biomatemat, Ist Anal Sistemi & Informat A Ruberti, IASI, Rome, Italy
[6] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Dept Med 3, Dresden, Germany
[7] Kings Coll London, Sch Cardiovasc & Metab Med & Sci, Div Diabet & Nutr Sci, London, England
关键词
citrate; de novo lipogenesis; dodecanedioic acid (DC12); glucose tolerance; metabolic dysfunction-associated steatohepatitis (MASH); obesity; DE-NOVO LIPOGENESIS; HEPATIC INSULIN-RESISTANCE; FATTY LIVER; ADIPOSE-TISSUE; STEATOSIS; TRIGLYCERIDES; INFUSION; KINETICS;
D O I
10.1096/fj.202402108R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dodecanedioic acid (DC12) is a dicarboxylic acid present in protective polymers of fruit and leaves. We explored the effects of DC12 on metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DC12 supplementation (100 mg/kg/day) was added to a high-fat diet (HFD) for 8 weeks in rodents to assess its impact on obesity and MASH prevention. Rats given DC12 experienced significant reductions of weight gain, liver and visceral fat weight, and improved glucose tolerance and insulin sensitivity. Liver histology showed protection against diet-induced MASH, with reduced steatosis, hepatocyte ballooning, and fibrosis. For weight-loss and MASH reversion, rats were fed HFD for 14 weeks, followed by 6 weeks with or without DC12. DC12 supplementation (100 mg/kg/day) led to a significant reduction of weight gain and liver weight. DC12 induced white adipose tissue beiging and reduced adiposity with a decrease of visceral fat. It also improved glucose tolerance, insulin sensitivity, and reduced hepatic gluconeogenic gene expression. Liver histology revealed a significant reduction in steatosis, hepatocyte ballooning, and inflammation as well as fibrosis, indicating MASH reversal. DC12 reduced hepatic lipogenesis enzymes as well as de novo lipogenesis measured by deuterated water and increased fatty acid beta-oxidation. Plasma lipid profile showed lower triglycerides and phosphatidylcholines in the DC12 group. Notably, DC12 decreased mINDY expression, the cell membrane Na+-coupled citrate transporter, reducing citrate uptake and de-novo lipogenesis, linking its effects to improved lipid metabolism and reduced steatosis. We found that during the hepatic first pass, half of the DC12 ingested with water was taken up by the liver. The concentration of DC12 in the portal vein falls within the range identified in vitro as sufficient to inhibit citrate transport in hepatocytes.
引用
收藏
页数:13
相关论文
共 50 条
[1]   Lipogenesis inhibitors: therapeutic opportunities and challenges [J].
Batchuluun, Battsetseg ;
Pinkosky, Stephen L. ;
Steinberg, Gregory R. .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) :283-305
[2]   Kinetics of dodecanedioic acid and effect of its administration on glucose kinetics in rats [J].
Bertuzzi, A ;
Mingrone, G ;
DeGaetano, A ;
Gandolfi, A ;
Greco, AV ;
Salinari, S .
BRITISH JOURNAL OF NUTRITION, 1997, 78 (01) :143-153
[3]  
Bertuzzi A, 2000, J PHARMACOL EXP THER, V292, P846
[4]   Deletion of the Mammalian INDY Homo log Mimics Aspects of Dietary Restriction and Protects against Adiposity and Insulin Resistance in Mice [J].
Birkenfeld, Andreas L. ;
Lee, Hui-Young ;
Guebre-Egziabher, Fitsum ;
Alves, Tiago C. ;
Jurczak, Michael J. ;
Jornayvaz, Francois R. ;
Zhang, Dongyang ;
Hsiao, Jennifer J. ;
Martin-Montalvo, Alejandro ;
Fischer-Rosinsky, Antje ;
Spranger, Joachim ;
Pfeiffer, Andreas F. ;
Jordan, Jens ;
Fromm, Martin F. ;
Koenig, Joerg ;
Lieske, Stefanie ;
Carmean, Christopher M. ;
Frederick, David W. ;
Weismann, Dirk ;
Knauf, Felix ;
Irusta, Pablo M. ;
De Cabo, Rafael ;
Helfand, Stephen L. ;
Samuel, Varman T. ;
Shulman, Gerald I. .
CELL METABOLISM, 2011, 14 (02) :184-195
[5]   Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD [J].
Bril, Fernando ;
Sninsky, John J. ;
Baca, Arthur M. ;
Superko, H. Robert ;
Sanchez, Paola Portillo ;
Biernacki, Diane ;
Maximos, Maryann ;
Lomonaco, Romina ;
Orsak, Beverly ;
Suman, Amitabh ;
Weber, Michelle H. ;
McPhaul, Michael J. ;
Cusi, Kenneth .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (02) :644-652
[6]   High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold [J].
Castera, Laurent ;
Laouenan, Cedric ;
Vallet-Pichard, Anais ;
Vidal-Trecan, Tiphaine ;
Manchon, Pauline ;
Paradis, Valerie ;
Roulot, Dominique ;
Gault, Nathalie ;
Boitard, Christian ;
Terris, Benoit ;
Bihan, Helene ;
Julla, Jean-Baptiste ;
Radu, Alina ;
Poynard, Thierry ;
Brzustowsky, Angelique ;
Larger, Etienne ;
Czernichow, Sebastien ;
Pol, Stanislas ;
Bedossa, Pierre ;
Valla, Dominique ;
Gautier, Jean-Francois .
DIABETES CARE, 2023, 46 (07) :1354-1362
[7]   Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease [J].
Fabbrini, Elisa ;
Mohammed, B. Selma ;
Magkos, Faidon ;
Korenblat, Kevin M. ;
Patterson, Bruce W. ;
Klein, Samuel .
GASTROENTEROLOGY, 2008, 134 (02) :424-431
[8]   Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? [J].
Fallowfield, Jonathan ;
Hayes, Peter .
CLINICAL MEDICINE, 2011, 11 (02) :179-183
[9]   Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin [J].
Fullerton, Morgan D. ;
Galic, Sandra ;
Marcinko, Katarina ;
Sikkema, Sarah ;
Pulinilkunnil, Thomas ;
Chen, Zhi-Ping ;
O'Neill, Hayley M. ;
Ford, Rebecca J. ;
Palanivel, Rengasamy ;
O'Brien, Matthew ;
Hardie, D. Grahame ;
Macaulay, S. Lance ;
Schertzer, Jonathan D. ;
Dyck, Jason R. B. ;
van Denderen, Bryce J. ;
Kemp, Bruce E. ;
Steinberg, Gregory R. .
NATURE MEDICINE, 2013, 19 (12) :1649-1654
[10]   Fatty Liver Is Associated with Insulin Resistance, Risk of Coronary Heart Disease, and Early Atherosclerosis in a Large European Population [J].
Gastaldelli, Amalia ;
Kozakova, Michaela ;
Hojlund, Kurt ;
Flyvbjerg, Allan ;
Favuzzi, Angela ;
Mitrakou, Asimina ;
Balkau, Beverley .
HEPATOLOGY, 2009, 49 (05) :1537-1544